 |
Acorda Therapeutics
ACOR
|
-1.2 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
-0.826 |
- |
- |
$ 86.2 M |
USA |
 |
MorphoSys AG
MOR
|
-0.654 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Alterity Therapeutics Limited
ATHE
|
-94.9 |
$ 3.73 |
- |
$ 8.97 B |
Australia |
 |
Akouos
AKUS
|
-2.7 |
- |
0.23 % |
$ 488 M |
USA |
 |
Alnylam Pharmaceuticals
ALNY
|
77.9 |
$ 333.39 |
- |
$ 43.7 B |
USA |
 |
Applied Molecular Transport
AMTI
|
-0.236 |
- |
- |
$ 10.1 M |
USA |
 |
I-Mab
IMAB
|
-0.266 |
- |
- |
$ 866 M |
China |
 |
AlloVir
ALVR
|
-0.632 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Burford Capital Limited
BUR
|
11.6 |
$ 4.73 |
- |
$ 784 M |
Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 |
- |
- |
$ 40.3 B |
USA |
 |
Cabaletta Bio
CABA
|
-2.16 |
$ 3.4 |
- |
$ 342 M |
USA |
 |
Genfit SA
GNFT
|
1.68 K |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
-23.1 |
- |
-13.47 % |
$ 169 M |
France |
 |
Aligos Therapeutics
ALGS
|
-0.799 |
$ 7.42 |
- |
$ 73.3 M |
USA |
 |
Allakos
ALLK
|
-0.976 |
- |
- |
$ 28.6 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-0.537 |
$ 3.17 |
- |
$ 5.22 M |
Israel |
 |
Ayala Pharmaceuticals
AYLA
|
-0.224 |
- |
- |
$ 7.46 M |
Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
-13.2 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Applied Therapeutics
APLT
|
-9.8 |
- |
- |
$ 8.42 M |
USA |
 |
Aptinyx
APTX
|
-0.159 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
-0.928 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.696 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
CNS Pharmaceuticals
CNSP
|
-0.0767 |
$ 2.75 |
4.16 % |
$ 1.22 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
8 |
$ 21.68 |
- |
$ 1.01 B |
USA |
 |
CymaBay Therapeutics
CBAY
|
-47.3 |
- |
- |
$ 3.45 B |
USA |
 |
BioNTech SE
BNTX
|
70.7 |
$ 99.47 |
- |
$ 27.2 B |
Germany |
 |
Институт стволовых клеток человека
ISKJ
|
-89 |
- |
- |
- |
Russia |
 |
Advaxis
ADXS
|
-0.0633 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Aeterna Zentaris
AEZS
|
-4.82 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
-0.0018 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
ContraFect Corporation
CFRX
|
-0.0235 |
- |
-5.16 % |
$ 5.39 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
4.92 |
$ 1.55 |
- |
$ 399 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
-0.64 |
- |
- |
$ 26.5 M |
USA |
 |
Aquestive Therapeutics
AQST
|
-8.91 |
$ 4.24 |
- |
$ 453 M |
USA |
 |
Galectin Therapeutics
GALT
|
-7.47 |
$ 2.56 |
- |
$ 164 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
-612 |
$ 24.58 |
- |
$ 3.13 B |
USA |
 |
AIkido Pharma
AIKI
|
-1.17 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
BioDelivery Sciences International
BDSI
|
7.5 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Genmab A/S
GMAB
|
4.08 |
$ 29.3 |
- |
$ 18.8 B |
Danmark |
 |
Autolus Therapeutics plc
AUTL
|
-1.14 |
$ 1.49 |
- |
$ 397 M |
Britain |
 |
Aptose Biosciences
APTO
|
-0.0645 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Checkpoint Therapeutics
CKPT
|
-5.15 |
- |
- |
$ 169 M |
USA |
 |
Caladrius Biosciences
CLBS
|
-0.185 |
- |
-16.75 % |
$ 25.8 M |
USA |
 |
Celldex Therapeutics
CLDX
|
-9.67 |
$ 33.87 |
- |
$ 2.25 B |
USA |
 |
AVROBIO
AVRO
|
-0.891 |
- |
1083.1 % |
$ 745 M |
USA |
 |
Clearside Biomedical
CLSD
|
-5.59 |
- |
- |
$ 25.3 M |
USA |